In accordance with our data, a receptor-independent but ROS-dependent upregulation of the HO-1 signaling pathway was finally also observed in breast cancer cells when fatty acid amide hydrolase, an important endocannabinoid-degrading enzyme, was inhibited or when the cells were exposed to the endocannabinoid anandamide [48]. Here, FAAH is linked to breast carcinoma.